Co-Founder & Chief Executive Officer
Karen has founded multiple start-ups and served in senior executive roles at Fortune 500 companies in the technology, media, and healthcare sectors. In the course of her work, she has generated over $300MM in strategic partnerships and alliances with companies such as Pearson Publishing and Compaq. As a start-up founder in Silicon Valley, she successfully raised $50M in private equity from seed financing through Series C.
Featured ResearchCo-Founder & Chief Executive Officer
Karen has founded multiple start-ups and served in senior executive roles at Fortune 500 companies in the technology, media, and healthcare sectors. In the course of her work, she has generated over $300MM in strategic partnerships and alliances with companies such as Pearson Publishing and Compaq. As a start-up founder in Silicon Valley, she successfully raised $50M in private equity from seed financing through Series C.
Founder, Director of Research and Development
Dr. Elizabeth Hood has worked in plant biology for more than 40 years, generating 80+ publications and patents. Her groundbreaking work developed the agrobacterial strain EHA101, which is now used globally for gene transfer into plants for crop improvement. In her work at Pioneer Hi-Bred International and ProdiGene, she developed the first commercialized product from a plant production system, and led an internationally recognized transgenic plant research group. Later, she served as a cell biology program director at the National Science Foundation.
Featured ResearchFounder, Director of Research and Development
Dr. Elizabeth Hood has worked in plant biology for more than 40 years, generating 80+ publications and patents. Her groundbreaking work developed the agrobacterial strain EHA101, which is now used globally for gene transfer into plants for crop improvement. In her work at Pioneer Hi-Bred International and ProdiGene, she developed the first commercialized product from a plant production system, and led an internationally recognized transgenic plant research group. Later, she served as a cell biology program director at the National Science Foundation.
Chairman of the Board
Kelly is the former owner and CEO of Armor Seed, LLC, an independent agricultural field seed company. During his 20-year tenure, Armor Seed grew from $5MM in sales to more than $100MM, becoming one of the top five independent seed companies in the United States. Armor Seed sold to Land O’Lakes in 2017.
Featured ResearchChairman of the Board
Kelly is the former owner and CEO of Armor Seed, LLC, an independent agricultural field seed company. During his 20-year tenure, Armor Seed grew from $5MM in sales to more than $100MM, becoming one of the top five independent seed companies in the United States. Armor Seed sold to Land O’Lakes in 2017.
Director of Manufacturing
Jeff served as a crew chief in the United States Air Force's 34th Fighter Squadron before becoming the director of operations at Armor Seed, LLC. He was part of the management team responsible for the company's success, leading to a Land O'Lakes acquisition in 2017. Over his 10+ years in operations, Jeff has gained extensive experience with research and development, production, manufacturing and distribution.
Featured ResearchDirector of Manufacturing
Jeff served as a crew chief in the United States Air Force's 34th Fighter Squadron before becoming the director of operations at Armor Seed, LLC. He was part of the management team responsible for the company's success, leading to a Land O'Lakes acquisition in 2017. Over his 10+ years in operations, Jeff has gained extensive experience with research and development, production, manufacturing and distribution.
Director of Corporate Development
Stephen has spent the past 21 years in the public sector, building public-private partnerships. He has worked most of his career at the Narragansett Bay Commission — a quasi-public agency that is tasked with running the 11th largest wastewater system in the country. More recently, Stephen has managed senior client issues for Inno360/Swarm Intelligence.
Featured ResearchDirector of Corporate Development
Stephen has spent the past 21 years in the public sector, building public-private partnerships. He has worked most of his career at the Narragansett Bay Commission — a quasi-public agency that is tasked with running the 11th largest wastewater system in the country. More recently, Stephen has managed senior client issues for Inno360/Swarm Intelligence.
Chief Science Officer
Maurice's career in biotechnology spans more than 35 years, during which time he served as a member of the Bill and Melinda Gates Foundation Science Advisory Board and led SemBioSys Genetics Inc. through its IPO on the Toronto Exchange.
Featured ResearchChief Science Officer
Maurice's career in biotechnology spans more than 35 years, during which time he served as a member of the Bill and Melinda Gates Foundation Science Advisory Board and led SemBioSys Genetics Inc. through its IPO on the Toronto Exchange.
Strategic Advisor
47-year history of high-profile successes as a C-Level and/or Senior Level Manager and Consultant in the Global Nutritional Products and Wellness industries.
Featured ResearchStrategic Advisor
47-year history of high-profile successes as a C-Level and/or Senior Level Manager and Consultant in the Global Nutritional Products and Wellness industries.
Strategic Advisor & Board Member
Paige spent over a decade at Goldman Sachs as an equity analyst covering companies in New York, Toronto and London. During her 17 years in London, she raised capital for investment funds, nonprofits, individuals, and startups around the globe
Featured ResearchStrategic Advisor & Board Member
Paige spent over a decade at Goldman Sachs as an equity analyst covering companies in New York, Toronto and London. During her 17 years in London, she raised capital for investment funds, nonprofits, individuals, and startups around the globe